Serum Neuroglobin and HIF-1α in Acute Ischemic Stroke

Completed

Phase N/A Results N/A

Summary of Purpose

Neuroglobin has shown rich neuroprotective effects against cerebral ischemia and hypoxia, and therefore has the potential to impact outcomes after acute ischemic stroke. Hypoxia inducible factor (HIF)-1α is neuroprotective in several models of experimental brain injury and is increased in brain after acute cerebral infarction in humans and experimental animals.The investigators sought to examine the changes in...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 11 August 2016.

1 Oct 2013 19 Nov 2014 1 Sep 2014 1 Oct 2014 1 Aug 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Conditions

Sponsors

Trial Design

  • Observation: Case-Only
  • Perspective: Prospective
  • Sampling: Probability Sample

Contacts

Not available